Disc Medicine, Inc. (IRON) — Financial statements
Income statement, balance sheet, and cash flow for Disc Medicine, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 171↑76.5% | 97↑39.6% | 69↑107.1% | 33↑32.8% | 25 | |
| General & Administrative Expenses | 65↑97.8% | 33↑51.2% | 22↑55.7% | 14↑143.6% | 6 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 65↑97.8% | 33↑51.2% | 22↑55.7% | 14↑143.6% | 6 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 236↑81.9% | 130↑42.4% | 91↑91.9% | 47↑53.5% | 31 | |
| Total Costs & Expenses | 236↑81.9% | 130↑42.4% | 91↑91.9% | 47↑53.5% | 31 | |
| Operating Results | ||||||
| Operating Income | -236↓81.9% | -130↓42.4% | -91↓91.9% | -47↓53.5% | -31 | |
| Depreciation & Amortization | 0.28↑80.1% | 0.16↑56.0% | 0.10↑12.4% | 0.09↑178.1% | 0.03 | |
| EBITDA | -208↓92.0% | -108↓42.0% | -76↓60.9% | -47↓53.3% | -31 | |
| EBIT | -208↓92.0% | -108↓42.1% | -76↓60.8% | -47↓53.5% | -31 | |
| Interest & Other Income | ||||||
| Net Interest Income | 24↑16.6% | 21↑40.0% | 15↑1987.0% | 0.71↑133.1% | -2 | |
| Interest Income | 28↑30.4% | 21↑43.9% | 15↑1987.0% | 0.71↑4964.3% | 0.01 | |
| Interest Expense | 4↑530.6% | 0.57 | 0.00 | 0.00↓100.0% | 2 | |
| Non-Operating Income | -28↓30.6% | -21↓43.9% | -15 | 0.00 | 0.00 | |
| Other Income / Expenses | 24↑16.8% | 21↑40.0% | 15↑2183.2% | 0.65↑112.9% | -5 | |
| Income Before Tax | -212↓94.3% | -109↓42.8% | -76↓63.0% | -47↓30.2% | -36 | |
| Income Tax Expense | 0.36↑1.7% | 0.36↑258.6% | 0.10 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -212↓94.0% | -109↓43.1% | -76↓63.2% | -47↓30.2% | -36 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -212↓94.0% | -109↓43.1% | -76↓63.2% | -47↓30.2% | -36 | |
| Bottom-Line Net Income | -212↓94.0% | -109↓43.1% | -76↓63.2% | -47↓30.2% | -36 | |
| EPS (Basic) | -6.01↓51.8% | -3.96↓15.8% | -3.42↑92.4% | -45.05↓0.4% | -44.88 | |
| EPS (Diluted) | -6.01↓51.8% | -3.96↓15.8% | -3.42↑92.4% | -45.05↓0.4% | -44.88 | |
| Weighted Average Shares | 35↑27.9% | 28↑23.7% | 22↑2046.8% | 1↑29.7% | 0.80 | |
| Weighted Average Diluted Shares | 35↑27.9% | 28↑23.7% | 22↑2046.8% | 1↑29.7% | 0.80 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.